Vivodyne was just named one of Endpoints News’ top 11 companies to watch. The piece digs into how the...
Read more
Vivodyne just launched the world’s largest human biological datacenter: 12 robotic laboratories capable of running 3.1 million living human...
Read more
Vivodyne CEO Andrei Georgescu was featured in Nature Biotechnology on how AI-powered human tissue models are reshaping preclinical drug...
Read more
Vivodyne was recently featured in The Healthcare Technology Report, where CEO Andrei Georgescu shared how the company is reimagining drug...
Read more
Vivodyne has raised $40 million in new Series A financing to scale its robotics+AI approach to testing on thousands...
Read more
The future of drug development is changing, and Vivodyne is helping lead the way. With the FDA’s new push...
Read more
From childhood aspirations of being a doctor to a pivotal role in lab operations, Lois Tolvinski’s journey highlights the...
Read more
Vivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development,...
Read more
Biotech startup Vivodyne is planning to revolutionize drug development with an AI-powered robot that can grow, dose, and analyze...
Read more
Vivodyne announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos...
Read more